Effect of a dopamine agonist on the development of Leydig cell hyperplasia in Sprague-Dawley rats

Toxicology and Applied Pharmacology

Volumn 141, Issue 1, 1996, Pages 169-177

  Dirami, Ghenima ^a,b   Teerds, Katja J ^c   Cooke, Brian A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; MESULERGINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL COUNT; CELL HYPERPLASIA; CONTROLLED STUDY; FOOD INTAKE; HISTOLOGY; INTERSTITIAL FLUID; LEYDIG CELL; LEYDIG CELL TUMOR; MACROPHAGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEMINAL VESICLE; TESTIS;

ANIMALIA;

EID: 0030297215     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0273     Document Type: Article

References (57)

1. Amador, A., Steger, R. W., Bartke, A., Johns, A., Siler-Khodr, T. M., Parker, C. R., and Sheferd, A. M. (1985). Testicular LH receptors during ageing in Fisher 344 rats. J. Androl. 6, 61-64.
2. Bartke, A., Sweeney, C. A., Johnson, L., Castracane, V. D., and Doherty, P. C. (1985). Hyperprolactinaemia inhibits development of Leydig cell tumours in ageing Fisher rats. Exp. Aging Res. 11, 123-128.
3. Biegel, L. B., Liu, R. C. M., Hurtt, M. E., and Cook, J. C. (1995). Effects of ammonium perfluorooctanoate on Leydig cell function: In vitro, in vivo, and exvivo studies. Toxicol. Appl. Pharmacol. 134, 18-25.
4. Biskind, M. S., and Biskind, G. R. (1945). Tumor of rat testis produced by heterotransplantation of infantile testis to spleen of adult castrate. Proc. Soc. Exp. Biol. Med. 59, 4-8.
5. Bortolussi, M., Zanchetta, R., Belvedere, P., and Colombo, L. (1990). Sertoli and Leydig cell numbers and gonadotrophin receptors in rat testis from birth to puberty. Cell Tissue Res. 260, 185-191.
6. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. Brimblecombe, R. W., and Leslie, G. B. (1984). Cimetidine. In Safety Testing of New Drugs, (D. R. Laurence, A. E. M. McLean, and M. Weatherall, Eds.), pp. 65-91. Academic Press.
8. Brown, C. E., Warren, S., Chute, R. N., Ryan, K. J., and Todd, R. B. (1979). Hormonally induced tumors of the reproductive system of parabiosed male rats. Cancer Res. 39, 3971-3976.
9. Bureau of National Affairs (1988). Environmental group considering challenge to EPA position on cancer risk from linuron. Chem. Regul. Rep. 12, 774-800.
10. Carter, D. A., and Whitehead, S. A. (1981). Pituitary sensitivity to gonadotrophin releasing hormone after hyperprolactinaemia induced with neuroleptics and domperidone in the rat. J. Endocrinol. 91, 439-446.
11. Chatani, F., Nonoyama, T., Sudo, K., Miyajima, H., Takeyama, M., Takatsuka, D., Mori, H., and Matsumoto, K. (1990). Stimulatory effect of luteinizing hormone on the development and maintenance of 5α-reduced steroid-producing testicular interstitial cell tumors in Fischer 344 rats. Anticancer Res. 10, 337-342.
12. Cheung, C. Y. (1983). Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone releasing hormone by a direct action at the anterior pituitary. Endocrinology 113, 632-638.
13. Christensen, A. K., and Peacock, K. C. (1980). Increase in Leydig cell number in testes of adult rats treated chronically with an excess of human chorionic gonadotrophin. Biol. Reprod. 22, 383-391.
14. Cook, J. C., Murray, S. M., Frame, R. S., and Hurtt, M. E. (1992). Induction of Leydig cell adenomas by ammonium perfluorooctanoate: A possible endocrine related mechanism. Toxicol. Appl. Pharmacol 113, 209-217.
15. Cook, J. C., Mullin, L. S., Frame, S. R., and Biegel, L. B. (1993). Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats. Toxicol. Appl. Pharmacol 119, 195-204.
16. Cooke, B. A., Magee-Brown, R., Golding, M., and Dix, C. J. (1981). The heterogeneity of Leydig cells from mouse and rat testes, evidence for a Leydig cell cycle? Int. J. Androl. 4, 355-366.
17. Cooke, B. A., Aldred, L. F., Hunter, M. G., Sullivan, M. H. F., and Dix, C. J. (1983). Effects of isolation and purification procedures on the viability and properties of testis Leydig cells. J. Steroid Biochem. 19, 359-366.
18. Corrie, D., Norbeck, J. C., Thompson, I. M., Rodriguey, F., Teague, J. L., Rouder, J. B., and Spence, C. R. (1987). Ultrasound detection of bilateral Leydig cell tumours in palpable normal testes. J. Urol. 137, 747-748.
19. Davila, D. R., Edwards III, C. K., Arkins, S., Simon, J., Kelly, K. W. (1990). Interferon-gamma-induced priming for secretion of superoxide anion and tumour necrosis factor-α declines in macrophages from aged rats. FASEB J. 4, 2906-2911.
20. De Kretser, D. M., and Kerr, J. B. (1994). The cytology of the testis. In The Physiology of Reproduction (E. Knobil and Knobil Neill, Eds.), pp. 1177-1290. Raven Press, New York, NY.
21. Dirami, G., Poulter, L. W., and Cooke, B. A. (1991). Separation and characterization of Leydig cells and macrophages from rat testes. J. Endocrinol. 130, 357-365.
22. Eccles, S. A., and Alexander, P. (1974). Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature 250, 667-669.
23. Ettlin, R. A., Qureshi, S. R., Perentes, E., Christen, H., Gschwind, R., Buser, M. W., and Oberholzer, M. (1992). Morphological, immunohistochemical, stereological and nuclear shape characteristics of proliferative Leydig cell alterations in rats. Pathol Res. Practice 188, 643-648.
24. Euflex (Flutamide) (1984). Product Monograph. Schering Canada, Inc., Pointe Claire, Quebec.
25. Fave, G. F. D., Tamburrano, G., de Magitris, L., Natoli, C., Sautoro, M. L., Carrutu, R., and Torsoli, A. (1977). Gynaecomastia with cimetidine. Lancet 1, 1319.
26. Fidler, I. J. (1976). Macrophage deficiency in tumour bearing animals: control of experimental metastasis with macrophages activated in vitro. In The Macrophage in Neoplasia (M. A. Fink, Ed.), pp. 245-257. Academic Press, New York, San Francisco, London.
27. Hardy, M. P., Zirkin, B. R., and Ewing, L. L. (1989). Kinetic studies on the development of the adult population of Leydig cells in testes of pubertal rats. Endocrinology 124, 762-770.
28. Heller, C. G., and Leach, D. R. (1971). Quantification of Leydig cells and measurement of Leydig-cell size following administration of human chorionic gonadotrophin to normal men. J. Reprod. Fertil. 25, 185-192.
29. Heller, C. G., Calli, M. F., Pearson, J. E., and Leach, D. R. (1971). Method for quantification of Leydig cells in man. J. Reprod. Fertil. 25, 177-184.
30. Hodgson, Y., and Hudson, B. (1983). Leydig cell function. Monogr. Endocrinol. 25, 107-132.
31. Hodson, C. A., Simkins, J. W., Aylsworth, C. F., Steger, R. W., and Meites, J. (1980). Effects of a prolactin secreting pituitary tumour on hypothalamic, gonadotropic, and testicular function in male rats. Neuroendocrinology 30, 7-10.
32. Hosakawa, S., Murakami, M., Ineyama, M., Yamada, T., Yoshitake, A., Yamada, H., and Miyamoto, J. (1993a). The affinity of procymidone to androgen receptor in rats and mice. J. Toxicol. Sci. 18, 83-93.
33. Hosakawa, S., Murakami, M., Ineyama, M., Yamada, T., Koyama, Y., Okuno, Y., Yoshitake, A., Yamada, H., and Miyamoto, J. (1993b). Effects of procymidone on reproductive organs and serum gonadotropins in male rats. J. Toxicol. Sci. 18, 111-124.
34. Kelly, P. M. A., Davison, R. S., Bliss, E., and McGee, J. O. D. (1988). Macrophages in human breast disease: A quantitative immunohistochemical study. Br. J. Cancer 57, 174-177.
35. Kullander, S. (1960). On tumor formation in gonadal and hypophyseal transplants into the anterior eye chambers of gonadectomized rats. Cancer Res. 20, 1079-1082.
36. Leon, M. D., Chiauzzi, V. A., Calvo, J. V., Charreau, E. H., and Chemes, H. E. (1987). Acute hCG administration induces seminiferous tubule damage in the adult rat. Acta Physiol. Pharmacol. Latinoam 37, 277-288.
37. Maddocks, W. O., and Nelson, W. O. (1952). The effect of chorionic gonadotropin in adult men: Increased oestrogen and 17-ketosteroid excretion, gynecomastia, Leydig cell stimulation and seminiferous tubule damage. J. Clin. Endocrinol. Metab. 12, 985-1007.
38. Maddocks, S., and Sharpe, R. M. (1989). Interstitial fluid volume in the rat testis: Androgen-dependent regulation by the seminiferous tubules. J. Endocrinol. 120, 215-222.
39. Mostofi, T. K., and Bresler, V. M. (1976). Tumours of the testis. In Pathology of Tumours in Laboratory Animals, Vol. I, Tumours of the Rat, Part 2 (V. S. Turusov, Ed.), pp. 135-150. World Health Organization International Agency for Research on Cancer, Lyon, France.
40. Physicians Desk Reference (1992). 8th ed, Vol. 46, pp. 2089-2090. Medical Economics Data, Oradell, NJ.
41. Prahalada, S., Majka, J. A., Soper, K. A., Nett, T. M., Bagdon, W. J., Peter, C. P., Burek, J. D., MacDonald, J. S., and van Zwieten, M. J. (1994). Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism. Fundam. Appl. Toxicol. 22, 211-219.
42. Prentice, D. E., Siegel, R. A., Donatsch, P., Qureshi, S., and Ettlin, R. A. (1992). Mesulergine induced Leydig cell tumors, a syndrome involving the pituitary-testicular axis of the rat. Arch. Toxicol. Suppl. 15, 197-204.
43. Prentice, D. E., and A. W. Meikle. (1995). A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat and some comparisons with man. Hum. Exp. Toxicol. 14, 562-572.
44. Raburn, D. J., Coquelin, A., and Hitson, J. C. (1991). Human chorionic gonadotrophin increases the concentration of macrophages in neonatal rat testis. Biol. Reprod. 45, 172-177.
45. Roberts, S. A., Nett, T. M., Hartman, H. A., Adams, T. E., and Stoll, R. E. (1989). SDZ 200-110 induces Leydig cell tumors by increasing gonadotropins in rats. J. Am. Coll. Toxicol. 8, 487-505.
46. Rudman, D., Kutner, M. H., Rogers, C. M., Lubin, M. F., Fleming, A., and Bain, R. P. (1981). Impaired growth hormone secretion in the adult population: relation to age and adiposity. J. Clin. Invest. 67, 1361-1369.
47. Sharpe, R. M., and Cooper, I. (1983). Testicular interstitial fluid as a monitor for changes in the intratesticular environment in the rat. J. Reprod. Fertil. 69, 125-135.
48. Smith, M. S., and Bartke, A. J. (1987). Effect of hyperprolactinaemia on the control of luteinizing hormone and follicle-stimulating hormone secretion in the male rat. Biol. Reprod. 36, 138-147.
49. Teerds, K. J., de Rooij, D. G., Rommerts, F. F. G., and Wensing, C. J. G. (1988). The regulation of the proliferation and differentiation of Leydig cell precursors after EDS administration or daily hCG treatment. J. Androl. 9, 343-351.
50. Teerds, K. J., De Rooij, D. G., De Jong, F. H., and Rommerts, F. F. G. (1991). Rapid development of Leydig cell tumors in a Wistar rat substrain. J. Androl. 12, 171-179.
51. Viguier-Martinez, M. C., Hochereau de Reviers, M. T., Barento, B., and Perreau, C. (1983a). Effect of a non-steroidal antiandrogen, flutamide on the hypothalamo-pituitary axis, genital tract and testis in immature rats: Endocrinological and histological data. Acta Endocrinol. 102, 299-306.
52. Viguier-Martinez, M. C., Hochereau de Reviers, M. T., Barenton, B., and Perreau, C. (1983b). Endocrinological and histological changes induced by flutamide treatment on the hypothalamo-hypophydeal testicular axis of the adult male rat and their incidences on fertility. Acta Endocrinol. 104, 246-252.
53. Widmark, A., Damber, J. E., and Bergh, A. (1986). Relationship between human chorionic gonadotrophin-induced changes in testicular microcirculation and the formation of testicular interstitial fluid. J. Endocrinol. 109, 419-425.
54. Widmark, A., Damber, J. E., and Bergh, A. (1987). Effect of oestradiol 17β on testicular microcirculation in rats. J. Endocrinol. 115, 489-495.
55. Yamada, T., Nakamura, J., Murakami, M., Okuno, Y., Hosokawa, S., Matsuo, M., and Yamada, H. (1994). The correlation of serum luteinizing hormone levels with the induction of Leydig cell tumors in rats by oxolinic acid. Toxicol. Appl. Pharmacol. 129, 146-154.
56. Yamada, T., Nakamura, J., Murakami, M., Okuno, Y., Hosokawa, S., Matsuo, M., and Yamada, H. (1995). Effect of chronic L-DOPA administration on serum luteinizing hormone levels in male rats. Toxicology 97, 173-182.
57. Zylber-Haran, E. A., Gershman, H., Rosenmann, E., and Spitz, I. M. (1982). Gonadotrophin, testosterone and prolactin interrelationships in cadmium-treated rats. J. Endocrinol 92, 123-130.